TESSERA
Flagship VL58, Inc.
Mark For: TESSERA® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88642455 |
| Registration Number | 6494020 |
| Mark Literal Elements | TESSERA |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-08-04 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Christina M. Licursi, Esq. |
| Attorney Docket Number | F08172000300 |
Timeline
| 2019-10-04 | Application Filed |
| 2019-10-08 | Location: NEW APPLICATION PROCESSING |
| 2019-10-08 | Status: Live/Pending |
| 2019-11-12 | Transaction Date |
| 2020-06-09 | Published |
| 2020-08-04 | Location: INTENT TO USE SECTION |
| 2021-02-01 | Status: A first request for extension of time to file a Statement of Use has been granted. |
| 2021-09-21 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Flagship VL58, Inc. |
| Address | 55 Cambridge Parkway, Suite 800E Cambridge, MASSACHUSETTS UNITED STATES 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
| Party: | TESSERA THERAPEUTICS, INC. |
| Address | 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE, MASSACHUSETTS UNITED STATES 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
*multiple parties listed, check assignment documents for ownership information
Documents
 Drawing | JPEG | 2019-10-04 |
 TEAS RF New Application | MULTI | 2019-10-04 |
| Preliminary Amendment | XML | 2019-11-12 |
| Amendment and Mail Process Complete | MULTI | 2019-11-13 |
| Offc Action Outgoing | XML | 2020-01-09 |
| XSearch Search Summary | XML | 2020-01-09 |
| Response to Office Action | MULTI | 2020-04-20 |
| Amendment and Mail Process Complete | MULTI | 2020-04-21 |
| Notation to File | XML | 2020-04-27 |
| Examiners Amendment | XML | 2020-04-28 |
| Amendment and Mail Process Complete | MULTI | 2020-04-29 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-04-30 |
| Notice of Publication | XML | 2020-05-20 |
| Notification Of Notice of Publication | XML | 2020-05-20 |
| OG Publication Confirmation | XML | 2020-06-09 |
| Notice of Allowance | XML | 2020-08-04 |
| Extension of Time to File SOU | MULTI | 2021-02-01 |
| ITU Extension Approval | XML | 2021-02-03 |
| ITU Unit Action | MULTI | 2021-02-03 |
Attorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: Agents for scientific and research use, namely, for manipulating or modifying DNA; pharmaceutical preparations, therapeutic agents and products, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders; technology for enabling the engineering and modification of DNA, namely, molecular and cellular biology reagents, techniques and assays for the modification of cells and DNA
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Agents for scientific and research use, namely, for manipulating or modifying DNA; pharmaceutical preparations, therapeutic agents and products, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders; technology for enabling the engineering and modification of DNA, namely, molecular and cellular biology reagents, techniques and assays for the modification of cells and DNA |
| GS0011 | Chemical and biological agents for scientific and research use, namely, for manipulating or modifying DNA; technology for enabling the engineering and modification of DNA, namely, molecular and cellular biology reagents and assays for the modification of cells and DNA |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 6880-0430 [2 Pages] | 2020-03-03 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-02-03 | |
| TEAS EXTENSION RECEIVED | 2021-02-01 | |
| EXTENSION 1 GRANTED | 2021-02-01 | 98765 |
| EXTENSION 1 FILED | 2021-02-01 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-08-04 | |
| PUBLISHED FOR OPPOSITION | 2020-06-09 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-06-09 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-05-20 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-04-29 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-04-28 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2020-04-28 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2020-04-28 | 94363 |
| EXAMINER'S AMENDMENT ENTERED | 2020-04-28 | 88888 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-20 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-04-20 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-20 | 88889 |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2020-03-11 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-01-09 | 6325 |
| NON-FINAL ACTION WRITTEN | 2020-01-09 | 94363 |
| NON-FINAL ACTION E-MAILED | 2020-01-09 | 6325 |
| ASSIGNED TO EXAMINER | 2020-01-09 | 94363 |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2019-11-12 | |
| TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | 2019-11-12 | 88889 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-10-08 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 